These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33941763)

  • 21. Molecular diversity of VEGF-A as a regulator of its biological activity.
    Woolard J; Bevan HS; Harper SJ; Bates DO
    Microcirculation; 2009 Oct; 16(7):572-92. PubMed ID: 19521900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process.
    Dehghanian F; Hojati Z; Kay M
    Avicenna J Med Biotechnol; 2014 Oct; 6(4):192-9. PubMed ID: 25414781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
    Hulse RP; Drake RA; Bates DO; Donaldson LF
    Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.
    Rennel ES; Varey AH; Churchill AJ; Wheatley ER; Stewart L; Mather S; Bates DO; Harper SJ
    Br J Cancer; 2009 Oct; 101(7):1183-93. PubMed ID: 19707198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.
    Ladomery MR; Harper SJ; Bates DO
    Cancer Lett; 2007 May; 249(2):133-42. PubMed ID: 17027147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.
    Perrin RM; Konopatskaya O; Qiu Y; Harper S; Bates DO; Churchill AJ
    Diabetologia; 2005 Nov; 48(11):2422-7. PubMed ID: 16193288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
    Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
    Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
    Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
    Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease.
    Kikuchi R; Stevens M; Harada K; Oltean S; Murohara T
    Adv Clin Chem; 2019; 88():1-33. PubMed ID: 30612603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression.
    Beazley-Long N; Gaston K; Harper SJ; Orlando A; Bates DO
    Am J Cancer Res; 2015; 5(1):433-41. PubMed ID: 25628951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.
    Gammons MV; Lucas R; Dean R; Coupland SE; Oltean S; Bates DO
    Br J Cancer; 2014 Jul; 111(3):477-85. PubMed ID: 25010863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale.
    Harris S; Craze M; Newton J; Fisher M; Shima DT; Tozer GM; Kanthou C
    PLoS One; 2012; 7(5):e35231. PubMed ID: 22567098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of manipulating VEGF splice isoforms in oncology.
    Rennel ES; Harper SJ; Bates DO
    Future Oncol; 2009 Jun; 5(5):703-12. PubMed ID: 19519209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-A splicing: the key to anti-angiogenic therapeutics?
    Harper SJ; Bates DO
    Nat Rev Cancer; 2008 Nov; 8(11):880-7. PubMed ID: 18923433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the
    Fukushima S; Farea M; Maeta K; Rani AQM; Fujioka K; Nishio H; Matsuo M
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
    Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
    Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
    Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
    Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human VEGF165b protein is an effective anti-cancer agent in mice.
    Rennel ES; Hamdollah-Zadeh MA; Wheatley ER; Magnussen A; Schüler Y; Kelly SP; Finucane C; Ellison D; Cebe-Suarez S; Ballmer-Hofer K; Mather S; Stewart L; Bates DO; Harper SJ
    Eur J Cancer; 2008 Sep; 44(13):1883-94. PubMed ID: 18657413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.